Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Healthcare Copper
Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Synopsis of corporate update
View:
Post by MrTAteam on Jun 17, 2020 7:01am

Synopsis of corporate update

No tangible progress on any front.

Columbia contract cancelled.

Still haven't been able to get regulatory approval for antibody test.
Comment by wembley on Jun 17, 2020 7:53am
Maybe you should sell and move on. Making a synopsis of something that hasnt happened is wasting everyones time. Gl
Comment by MrTAteam on Jun 17, 2020 8:19am
Hey wembley, maybe you should read the corporate update released last night.
Comment by wembley on Jun 17, 2020 8:49am
MrTAteam, "In addition, MTJR has current purchase agreements which are conditional on US Food and Drug Administration Emergency Use Authorization (EUA). An application for EUA has been submitted to the US FDA and PCL is corresponding with an assigned reviewer. The timeline for receiving a final response is still unknown. MTJR is also working to satisfy the final conditions under the supply ...more  
Comment by bigmoney2020 on Jun 17, 2020 9:32am
I think one thing that is a bit alarming is that on Health Canada's website there are 5 serology tests approved and 23 under review and PCL is not one of them.  I think they are missiing their opportunity right now.  
Comment by wembley on Jun 17, 2020 10:14am
Post the link please.
Comment by bigmoney2020 on Jun 17, 2020 10:27am
These are under review: https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing/applications.html
Medivolve Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities